How Immune Cells Respond to Inner Ear Damage
Macrophage Response to Otic Pathology
This work explores how specialized immune cells called macrophages help the inner ear heal after damage, which is important for hearing and balance.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11139533 on NIH RePORTER |
What this research studies
Our inner ear contains delicate hair cells that are vital for hearing and balance, but these cells can be damaged by loud noises, certain medications, infections like CMV, or simply aging. When hair cells are injured, the body needs to clear away the damaged cells to allow for repair. This project looks closely at how two types of cells, supporting cells and macrophages, work together to identify and remove these damaged cells. Understanding this process could lead to new ways to protect or restore hearing and balance.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients, but future studies stemming from this work might benefit individuals experiencing hearing or balance loss due to injury, infection, or aging.
Not a fit: Patients whose hearing or balance issues are not related to inner ear hair cell damage or the body's immune response to such damage may not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that help the inner ear recover from damage, potentially preserving or restoring hearing and balance.
How similar studies have performed: While the role of immune cells in tissue repair is a known area of biology, this specific focus on the inner ear's unique healing mechanisms and macrophage behavior after otic injury is a novel and important area of investigation.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Warchol, Mark — Washington University
- Study coordinator: Warchol, Mark
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.